Skip to content

The impact of virulence factor expression in oral biofilms for the immune response

The impact of virulence factor expression in oral biofilms for the immune response - OralMicro

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00003366
Enrollment
36
Registered
2011-11-30
Start date
2010-03-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Young healthy volunteers K05.0

Interventions

Group 1: Young healthy volunteers stop their oral hygiene for 21 days. During this period the clinical signs of oral inflammation will be recorded. Parallel blood will be sampled and to detremine infl

Sponsors

Medizinische Hochschule Hannover
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 25 Years

Inclusion criteria

Inclusion criteria: No history of any systemic disease

Exclusion criteria

Exclusion criteria: Systemic diseases, periodontitis or caries, Medications that interfere with immune response 6 months before the start of the study, pregnancy

Design outcomes

Primary

MeasureTime frame
The systemic concentrations of hsCRP will be determined by immunnephelometrie at day 0, 21 and 42 in serum.

Secondary

MeasureTime frame
The systemic concentration of IL-6, MCP-1 will be measured in vitro by ELISA, for monocyte activation established assays will be used and the microbial diversity as well as the expression of virulence factors will be determined by sequencing techniques. All measurements will be performed at day 0, 21 and 42.

Countries

Germany

Contacts

Public ContactJörg Eberhard

Medizinische Hochschule Hannover

eberhard.joerg@mh-hannover.de0049 531 532-8308

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 24, 2026